InvestSMART

Underwood Capital Limited (ASX:UWC)

ALERT: Price-sensitive ASX Announcement for UWC
Current share price for UWC : $0.054 -0.001 (-1.82%)+
Announcement
Release
26 Feb 2026 9:37AM
Price at Release
$0.055
Full Release
download
Summary
Underwood Capital Limited's half-year report for the period ending 31 December 2025 highlights a substantial increase in financial performance, with revenues rising 356% and profit after tax increasing 460% compared to the previous period. This performance was mainly driven by gains in the market value of investments in listed Australian securities. Despite the rise in operating overheads due to higher asset management expenses, the company's net tangible assets per share increased significantly. No dividends were declared or paid during the period, and the company remains focused on its strategy of capital growth through investments in listed and unlisted equities and debt securities. The report also notes the winding up of a non-operating subsidiary and confirms no contraventions of auditor independence requirements.
Key Points
  • Underwood Capital Limited (UWC) reported a significant increase in revenues and profits for the half-year ended 31 December 2025.
  • Revenues from ordinary activities increased by 356% to $5.882 million, while profit after tax rose by 460% to $3.363 million.
  • The main driver of financial performance was the positive change in market value of UWC’s investments in listed Australian securities.
  • Operating overheads increased due to higher asset management expenses resulting from improved investment performance.
  • The net tangible assets per share increased from 9.3 cents to 10.9 cents due to the profit after tax of $3.4 million.
  • No dividends were declared or paid during the current or previous financial periods.
  • UWC's investment strategy focuses on producing capital growth over the medium term from investments in listed and unlisted equities and debt securities.
  • The company's risk management policy outlines methods to control material risks related to its business operations.
  • UWC voluntarily wound up a non-operating subsidiary, Phytotech Medical (UK) Pty Ltd, during the financial period.
  • The financial statements were reviewed by Connect National Audit Pty Ltd without any contraventions of the auditor independence requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.